Laurus Labs Ltd | Industry : (Pharmaceuticals) | |
---|---|---|
|
|
|
|
|
|
|
|
|
Mar '2024 | Mar '2023 | Mar '2022 | Mar '2021 | Mar '2020 | |
---|---|---|---|---|---|
SOURCES OF FUNDS : | |||||
Equity Share Capital | 107.79 | 107.73 | 107.47 | 107.32 | 106.91 |
Reserves | 4,099.26 | 3,949.09 | 3,280.74 | 2,604.92 | 1,708.89 |
Equity Share Warrants | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Equity Application Money | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Total Shareholders Funds | 4,207.05 | 4,056.82 | 3,388.21 | 2,712.24 | 1,815.80 |
Secured Loans | 1,479.64 | 1,134.07 | 1,260.95 | 1,256.60 | 846.89 |
Unsecured Loans | 630.18 | 580.19 | 392.15 | 154.66 | 204.41 |
Total Debt | 2,109.82 | 1,714.26 | 1,653.10 | 1,411.26 | 1,051.30 |
Other Liabilities | 114.70 | 124.53 | 136.82 | 131.94 | 101.28 |
Total Liabilities | 6,431.57 | 5,895.61 | 5,178.13 | 4,255.44 | 2,968.38 |
APPLICATION OF FUNDS : | |||||
Gross Block | 4,706.38 | 4,221.85 | 3,254.00 | 2,656.56 | 2,341.36 |
Less: Accumulated Depreciation | 1,670.07 | 1,337.69 | 1,067.77 | 838.52 | 647.18 |
Less:Impairment of Assets | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Block | 3,036.31 | 2,884.16 | 2,186.23 | 1,818.04 | 1,694.18 |
Lease Adjustments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Capital Work in Progress | 155.51 | 357.06 | 755.03 | 324.17 | 66.53 |
Investments | 634.87 | 384.12 | 361.72 | 318.89 | 58.32 |
Current Assets, Loans & Advances | |||||
Inventories | 1,697.16 | 1,569.27 | 1,688.70 | 1,533.52 | 893.47 |
Sundry Debtors | 1,640.50 | 1,487.42 | 1,269.15 | 1,279.82 | 778.04 |
Cash and Bank Balance | 42.92 | 1.70 | 40.56 | 38.78 | 0.93 |
Loans and Advances | 136.53 | 112.87 | 206.16 | 189.33 | 112.20 |
Total Current Assets | 3,517.11 | 3,171.26 | 3,204.57 | 3,041.45 | 1,784.64 |
Less : Current Liabilities and Provisions | |||||
Current Liabilities | 1,111.59 | 922.14 | 1,316.33 | 1,318.59 | 746.63 |
Provisions | 58.01 | 63.47 | 43.84 | 24.29 | 24.35 |
Total CL & Provisions | 1,169.60 | 985.61 | 1,360.17 | 1,342.88 | 770.98 |
Net Current Assets | 2,347.51 | 2,185.65 | 1,844.40 | 1,698.57 | 1,013.66 |
Miscellaneous Expenses not written off | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Deferred Tax Assets | 53.62 | 45.06 | 81.63 | 115.11 | 212.89 |
Deferred Tax Liability | 119.93 | 121.80 | 151.86 | 141.98 | 143.13 |
Net Deferred Tax | -66.31 | -76.74 | -70.23 | -26.87 | 69.76 |
Other Assets | 323.68 | 161.36 | 100.98 | 122.64 | 65.93 |
Total Assets | 6,431.57 | 5,895.61 | 5,178.13 | 4,255.44 | 2,968.38 |
Contingent Liabilities | 729.69 | 573.32 | 257.35 | 204.64 | 138.84 |